STERIS (STE) to Release Earnings on Wednesday

STERIS (NYSE:STE) is anticipated to post its Q3 2026 results after the market closes on Wednesday, February 4th. Analysts expect STERIS to post earnings of $2.53 per share and revenue of $1.4812 billion for the quarter. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Interested persons may visit the the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Thursday, February 5, 2026 at 9:00 AM ET.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the firm posted $2.14 EPS. On average, analysts expect STERIS to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

STERIS Trading Up 0.1%

NYSE:STE opened at $263.34 on Wednesday. The stock has a market cap of $25.85 billion, a price-to-earnings ratio of 37.84 and a beta of 1.03. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. The company’s 50 day moving average price is $259.10 and its 200-day moving average price is $248.17. STERIS has a 52 week low of $204.90 and a 52 week high of $269.44.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $273.50.

Insider Activity

In related news, VP Julia Madsen sold 5,008 shares of STERIS stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the sale, the vice president directly owned 10,710 shares in the company, valued at $2,806,020. The trade was a 31.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Renato Tamaro sold 5,036 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the sale, the vice president owned 5,695 shares in the company, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 25,044 shares of company stock valued at $6,586,218. Insiders own 1.07% of the company’s stock.

Hedge Funds Weigh In On STERIS

A number of large investors have recently made changes to their positions in the business. State Street Corp raised its position in STERIS by 4.0% in the third quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock worth $1,077,564,000 after acquiring an additional 166,736 shares in the last quarter. Orbis Allan Gray Ltd grew its position in shares of STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after buying an additional 556,088 shares during the last quarter. Invesco Ltd. grew its position in STERIS by 4.9% in the 3rd quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider’s stock valued at $316,758,000 after buying an additional 59,443 shares in the last quarter. AQR Capital Management LLC raised its position in shares of STERIS by 178.6% during the third quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider’s stock worth $291,704,000 after purchasing an additional 758,423 shares during the period. Finally, Bank of America Corp DE boosted its position in STERIS by 24.3% during the 3rd quarter. Bank of America Corp DE now owns 890,277 shares of the medical equipment provider’s stock worth $220,290,000 after acquiring an additional 173,895 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.